Sionna Therapeutics (SION) Market Value

Public company logo of sionnatx.com (SION)

The price visualization for Sionna Therapeutics Inc (SION) shows a market capitalization of 0.15. The asset relies on the cystic fibrosis therapy development environment, where growth rates are driven by FDA approvals and venture capital funding. The discovery process for new compounds is accelerating through the implementation of AI and robotic systems. The business model is based on the capitalization of patents that transform scientific research into scalable mass production.

SION sionnatx.com: Market Capitalization in the range 02/08/2025 - 11/16/2026

Sionna Therapeutics Inc - analytical breakdowns and key metrics (SION)

- current price and projected stock value:
Fundamental company analysis:SION (Sionna Corp)
Original product of Sionna Corp

For the biotech startup Sionna Therapeutics Inc (SION), characterized by highly competent leadership and transparent cystic fibrosis research, market value serves as an indicator of investor confidence in the team's scientific potential. This market capitalization is calculated as the product of the current share price and the total number of outstanding shares, allowing for an assessment of the overall scale of the business and the identification of optimal entry points prior to a possible correction.

Analysis of competing companies

Market Capitalization TEM (Tempus AI, Inc)|Market Capitalization Qiagen Group|IONS - Market Value|Market Value repligen.com|RNA: Market Capitalization|Market Valuation CRSP (CRISPR Therapeutics)|Market Value GeneDx Holdings Corp.|Market Capitalization RARE (Ultragenyx Corp)|Market Value Beam Therapeutics (BEAM)|Sarepta Therapeutics, Inc. - Market Capitalization|Market Capitalization TWST (twistbioscience.com)|Market Value TXG (10x Genomics Corp)|Intellia Corp - Market Capitalization|Market Capitalization Stoke Therapeutics STOK|BLFS: Market Capitalization|WVE (Wave Life Sciences) - Market Value|Market Valuation MAZE|Prime Medicine Inc (PRME) - Market Capitalization|Market Value Taysha Corp (TSHA)|uniQure N.V. (QURE) - Market Capitalization|Market Capitalization MGTX (MeiraGTx Corp)|RGNX: Market Capitalization|SLDB: Market Valuation|OCGN (Ocugen Corp) - Market Capitalization|PACB: Market Capitalization|Market Valuation Benitec Biopharma Inc.|Market Valuation DSGN|Rocket Pharmaceuticals - Market Valuation|Market Capitalization FDMT|LXEO - Market Value|Korro Bio, Inc. - Market Valuation|EDIT: Market Capitalization|SLN - Market Value|PRQR - Market Capitalization|CDXS (Codexis, Inc.) - Market Valuation|Sangamo Therapeutics, Inc. - Market Value|Market Valuation NAUT|Market Valuation Metagenomi, Inc. (MGX)|Market Value precisionbiosciences.com (DTIL)|GBIO - Market Value|Market Capitalization BOLD (Boundless Bio Inc.)|Market Capitalization Exicure, Inc. XCUR|Imunon Inc - Market Capitalization|Market Capitalization phiopharma.com PHIO|Mustang Bio Corp (MBIO) - Market Value|Market Value TransCode Therapeutics (RNAZ)|BNGO (Bionano Genomics) - Market Capitalization|Market Valuation Applied DNA Sciences, Inc. (APDN)|Market Value Bluebird Bio (BLUE)|IPA - Market Value|Market Value omegatherapeutics.com OMGA|singulargenomics.com (OMIC) - Market Value|RGLS - Market Value|Market Capitalization Syros Pharmaceuticals Inc. SYRS|Telesis Bio, Inc. (TBIO) - Market Value|TCON - Market Capitalization|Market Value Unity Biotechnology, Inc.